vimarsana.com
Home
Live Updates
Nilogen Oncosystems Announces Opening of Clinical Trial Usin
Nilogen Oncosystems Announces Opening of Clinical Trial Usin
Nilogen Oncosystems Announces Opening of Clinical Trial Using Ex Vivo Tumoroids to Predict Immunotherapy Response in Non-Small Cell Lung Cancer (TUMORIN)
/PRNewswire/ -- Nilogen Oncosystems today announced that its clinical observational study TUMORIN (NCT05332925) has commenced enrolment. Patients with...
Related Keywords
Nilogen Oncsystems ,
Nilogen Oncosystems ,
,
Cell Therapies ,
Oncolytic Virus ,
Soner Altiok ,
Chief Scientific Officer ,